7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      3D Tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          An appropriate representation of the tumor microenvironment in tumor models can have a pronounced impact on directing combinatorial treatment strategies and cancer nanotherapeutics. The present study develops a novel 3D co-culture spheroid model (3D TNBC) incorporating tumor cells, enodothelial cells and fibroblasts as color-coded murine tumor tissue analogs (TTA) to better represent the tumor milieu of triple negative breast cancer in vitro. Implantation of TTA orthotopically in nude mice, resulted in enhanced growth and aggressive metastasis to ectopic sites. Subsequently, the utility of the model is demonstrated for preferential targeting of irradiated tumor endothelial cells via radiation-induced stromal enrichment of Galectin-1 using Anginex conjugated nanoparticles (nanobins) carrying arsenic trioxide and cisplatin. Demonstration of a multimodal nanotherapeutic system and inclusion of the biological response to radiation using an in vitro/ in vivo tumor model incorporating characteristics of tumor microenvironment presents an advance in preclinical evaluation of existing and novel cancer nanotherapies.

          Graphical Abstract

          3D TNBC tumor model of tumor tissue analogs (TTA) in vitro and their orthotopic implants to demonstrate radiation guided endothelial cell targeting

          Related collections

          Author and article information

          Journal
          101233142
          32817
          Nanomedicine
          Nanomedicine
          Nanomedicine : nanotechnology, biology, and medicine
          1549-9634
          1549-9642
          16 August 2015
          15 August 2015
          November 2015
          01 November 2016
          : 11
          : 8
          : 2013-2023
          Affiliations
          [1 ]Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, 789 South Limestone Street, KY, USA
          [2 ]Chemistry of Life Processes Institute, Department of Chemistry, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208-3113.
          [3 ] University of Kentucky Chandler Hospital, Department of Radiation Medicine, 800 Rose Street, Pavilion H Lexington, KY 40536-0293
          [4 ]Division of Biomedical Informatics, University of Kentucky, 725 Rose Street, Multidisciplinary Science Bldg, 230FLexington, KY 40536-0082
          Author notes
          Corresponding Author: Meenakshi Upreti 555 Biopharmaceutical Complex College of Pharmacy, University of Kentucky, 789 S. Limestone Street, Lexington, KY 40536-0596, USA m.upreti@ 123456uky.edu Phone number: +1-859-218-1041
          Article
          PMC4548830 PMC4548830 4548830 nihpa715977
          10.1016/j.nano.2015.07.013
          4548830
          26282381
          25220168-7e7a-4cce-9d89-c50442af9697
          History
          Categories
          Article

          3D co-cultures,Tumor tissue analogs (TTA),Tumor cell spheroids,galectin-1,tumor microenvironment,targeted nanoparticle,3 dimensional Triple negative breast cancer (3D TNBC) model

          Comments

          Comment on this article